Last spring FDA created an internal task force to develop recommendations for enhancing the transparency of FDA’s operations and decision-making processes. In recent months, the task force sought public comment on how to improve transparency through a public docket, an online blog, and two public meetings. Hundreds of comments were received from the regulated industry, patients, health care professionals, and consumers. On January 12, 2010, FDA announced it has completed the initial phase of this “Transparency Initiative” by rolling out a new Web-based feature for the public that provides basic information on the key program areas regulated by the agency.
Click the link below to read the full alert.